Cisatracurium Besylate Injection
Product Images NDC 72485-513

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Cisatracurium Besylate (NDC 72485-513). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Armas Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cisa Besylate Inj (72485 513 1)

Cisa Besylate Inj (72485 513 1)
Packaging labels for Cisatracurium Besylate Injection, USP 200 mg/20 mL (10 mg/mL) by Armas Pharmaceuticals. The inner vial label and outer carton label display warnings for use in ICU only, and that the product is a paralyzing agent for intravenous injection. The outer carton contains 10 single-dose 20 mL vials. Caplin Steriles and Armas logos appear on the labels. The product is sterile, nonpyrogenic, preservative free, and distributed by Armas Pharmaceuticals, manufactured by Caplin Steriles Limited in India.*
FDA Label Image

Fig-1 (Cisatracurium Besylate Figure 1)

Fig-1 (Cisatracurium Besylate Figure 1)
A scatter plot illustrating changes in heart rate (HR) and mean arterial pressure (MAP) as percentages, with axes ranging from -60% to +60%. Data points cluster near the center, showing variability in both HR and MAP values.*
FDA Label Image

Fig-2 (Cisatracurium Besylate Figure 2)

Fig-2 (Cisatracurium Besylate Figure 2)
A scatter plot chart depicts data points showing percentage changes in heart rate (HR) along the vertical axis and mean arterial pressure (MAP) along the horizontal axis, each ranging from -60% to +60%. The plot clusters many points near the center, indicating limited variation in HR and MAP values.*
FDA Label Image

Str (Cisatracurium Besylate Structure)

Str (Cisatracurium Besylate Structure)
Chemical structure diagram of Cisatracurium Besylate showing its molecular components and arrangement including methoxy groups and benzenesulfonate moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.